PNC Financial Services Group
ANTH

PNC Financial Services Group’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

PNC Financial Services Group’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-17,500
Closed -$650K – 4638
2015
Q4 		$650K Sell
17,500
-3,571
-17% -$158K ﹤0.01% 1399
2015
Q3 		$1.03M Buy
21,071
+5,971
+40% +$417K ﹤0.01% 1214
2015
Q2 		$1.04M Hold
15,100
– – ﹤0.01% 1255
2015
Q1 		$540K Buy
15,100
+15,087
+116,054% +$447K ﹤0.01% 1592
2014
Q4 		$0 Sell
13
-9,487
-100% -$138K ﹤0.01% 4319
2014
Q3 		$146K Hold
9,500
– – ﹤0.01% 2181
2014
Q2 		$258K Hold
9,500
– – ﹤0.01% 1778
2014
Q1 		$254K Hold
9,500
– – ﹤0.01% 1766
2013
Q4 		$234K Buy
9,500
+850
+10% +$21.9K ﹤0.01% 1794
2013
Q3 		$278K Buy
+8,650
New +$268K ﹤0.01% 1684

Other funds holding ANTH

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

PNC Financial Services Group's ANTH Position: Q1 2016 in Review

PNC Financial Services Group sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2016, closing a stake of 17,500 shares — an estimated $650K sold.

PNC Financial Services Group first reported a position in ANTH in Q3 2013 and held it in 10 quarters. The position peaked at $1.04M in Q2 2015. 72 funds tracked by Wall St. Rank hold ANTH as of Q1 2016.

  • PNC Financial Services Group reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • PNC Financial Services Group sold 17,500 Anthera Pharmaceuticals, Inc. shares in Q1 2016, an estimated $650K.
  • PNC Financial Services Group first reported a position in Anthera Pharmaceuticals, Inc. in Q3 2013 and held it in 10 quarters.
  • PNC Financial Services Group's Anthera Pharmaceuticals, Inc. position peaked at $1.04M in Q2 2015.
  • 72 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2016.

Based on PNC Financial Services Group's 13F filing for Q1 2016, filed 6 May 2016.